20 April 2025

Last updated: Wednesday 16 April 2025

Policy & Regulation

A window onto oncology drug success rates

The case for drug rediscovery

Ebola epidemic moves fast but response is gaining

Oncology Review: 2014 was a record year for approvals

Balance of power in pharmaceuticals is shifting

Highlights of the new EU Clinical Trials Regulation

Collaboration to deliver superior value to patients

A greater patient voice in drug development

The Case for HTA co-operation

Commentary: How are regulators are supporting innovation?